-The Times of India The government may be standing firm against scrapping coal block allotments to private companies but a high-level official panel for monitoring progress in these mines is pitching for largescale de-allocation to "defuse the current crisis" over Coalgate. "Out of the 90 coal blocks allocated to private players since 1993, 60 coal blocks with 6.7 billion tonnes (estimated reserves) valued at nearly Rs 2 lakh crore can be cancelled...

-The Times of India India's growth story is undeniable. But the 68th National Sample Survey Organization's (NSSO) findings seem to reaffirm that the benefits from this boost in the economy have been cornered by the upper crust, while the poorest continue to languish in near destitution. Compared with the previous survey, which was conducted in 2009-10, the monthly expenditure of the poorest 10% population in rural India has risen by only...

-The Guardian Higher disposable incomes, changing consumption patterns and the marketing might of powerful western brands are bringing fast food to India's children The camera pans in. The grins of smiling school children fill the frame. An enthusiastic teacher, played by a famous Bollywood actress, sits in the centre. The scene is a "remote picturesque setting". And all are munching happily on Domino's Pizza. The advert is typical of the marketing bombardment...

-The Indian Express India topped a list of 17-nation on best sustainable behaviour, with consumers in the US last on the list, according to a new survey. The global analysis by the National Geographic Society found that Indian consumers were the most conscious about their environment footprint and were more guilty about their impact despite having the best sustainable behaviour. Ironically, people in developing countries like India, China and Brazil -- in that...

-The Economic Times   Pushed to the wall by an overly cautious drug regulator and an alarmist Indian government, clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities.  Clinical research companies (CROs), that were aspiring to become billion- dollar companies by 2010, had to rework their plans after a Parliamentary Standing Committee report questioned the allegedly unfair and unethical trials...